American Century Companies
CRDF icon

American Century Companies’s Cardiff Oncology CRDF Stock Holding History

American Century Companies’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-53,955
Closed -$234K – 2901
2024
Q4 		$234K Buy
53,955
+6,140
+13% +$19.2K ﹤0.01% 2751
2024
Q3 		$128K Buy
47,815
+2,455
+5% +$5.8K ﹤0.01% 2817
2024
Q2 		$101K Buy
45,360
+22,536
+99% +$84.9K ﹤0.01% 2816
2024
Q1 		$122K Buy
+22,824
New +$60.7K ﹤0.01% 2843

Other funds holding CRDF

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

American Century Companies's CRDF Position: Q1 2025 in Review

American Century Companies sold out of Cardiff Oncology (CRDF) in Q1 2025, closing a stake of 53,955 shares — an estimated $234K sold.

American Century Companies first reported a position in CRDF in Q1 2024 and held it in 4 quarters. The position peaked at $234K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2025.

  • American Century Companies reported no remaining Cardiff Oncology position as of Q1 2025 after selling out during the quarter.
  • American Century Companies sold 53,955 Cardiff Oncology shares in Q1 2025, an estimated $234K.
  • American Century Companies first reported a position in Cardiff Oncology in Q1 2024 and held it in 4 quarters.
  • American Century Companies's Cardiff Oncology position peaked at $234K in Q4 2024.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2025.

Based on American Century Companies's 13F filing for Q1 2025, filed 13 May 2025.